| scholarly article | Q13442814 |
| P2093 | author name string | Jarrett WF | |
| Campo MS | |||
| Laird HM | |||
| Smith KT | |||
| O'Neil BW | |||
| Gaukroger JM | |||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 449-452 | |
| P577 | publication date | 1990-05-01 | |
| P1433 | published in | Veterinary Record | Q7923713 |
| P1476 | title | Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination | |
| P478 | volume | 126 |
| Q39879423 | A neutralizing epitope of human papillomavirus type 11 is principally described by a continuous set of residues which overlap a distinct linear, surface-exposed epitope |
| Q33955745 | Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein |
| Q36029314 | Cancer of the cervix: prospects for immunological control |
| Q35235035 | How will HPV vaccines affect cervical cancer? |
| Q41687595 | Immunomanipulative strategies for the control of human papillomavirus associated cervical disease |
| Q84423777 | In planta production of a candidate vaccine against bovine papillomavirus type 1 |
| Q42235183 | Lack of effect of recombinant bovine interferon alpha I1 in the treatment of experimentally-induced bovine warts. |
| Q37353496 | Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic |
| Q33614425 | Papillomavirus prophylactic vaccines: established successes, new approaches |
| Q33784703 | Rabbit genital tissue is susceptible to infection by rabbit oral papillomavirus: an animal model for a genital tissue-targeting papillomavirus. |
| Q40706832 | Reflections on viruses and cancer |
| Q33936363 | The role of vaccines in the control of STDs: HPV vaccines. |
| Q39875296 | Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11. |
Search more.